Skip to Content

D 70 (Didanosine Delayed Release 125 mg)

Pill with imprint D 70 is White, Capsule-shape and has been identified as Didanosine Delayed Release 125 mg. It is supplied by Aurobindo Pharma.

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D 70

Didanosine delayed release 125 mg D 70

Didanosine Delayed Release

Imprint:
D 70
Strength:
125 mg
Color:
White
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Aurobindo Pharma
National Drug Code (NDC):
65862-0310
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide